1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. EYEPOINT PHARMACEUTICALS INC
EyePoint Pharmaceuticals Inc XNAS: EYPT

EyePoint Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its...

Read More
9.84 -0.01 (-0.10%)
29.61% Fall from 52W High
466.6K
XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for EyePoint Pharmaceuticals Inc is on 07 Aug 2025 for the purpose of EyePoint Pharmaceuticals Inc Second Quarter Earnings Results for 2025 See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
13.8 / 100
Momentum Score
Technically Moderately Bullish
60.6 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
32
1Yr Price target upside is 222%
13 analysts

10

S

9

W

1

O

2

T

SWOT Analysis

EyePoint Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..